Clinical Trial

A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Study acronym: MEMENTO
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the mavacamten impact on myocardial structure with cardiac magnetic resonance imaging (CMR) in adult participants with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) \[New York Heart Association (NYHA) Functional Class II or III\].
Protocol Amendment History 1 change
minor Completion pushed: 2026-07-09 -> 2027-07-10 2026-08-07
Trial Details
NCT Number NCT06112743
Lead Sponsor Bristol-Myers Squibb
Conditions Cardiomyopathy, Hypertrophic
Enrollment 63 participants
Start Date 2024-01-24
Primary Completion 2026-07-16 (estimated)
Study Completion 2027-07-10 (estimated)
Updated on ClinicalTrials.gov 2026-08-06